PAR-24-304-Full-Announcement.html

This document is a Notice of Funding Opportunity (NOFO) for the Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed) federal grant opportunity. The purpose of this NOFO is to accelerate the translation of NCI-supported methods, assays, and technologies to the clinic, with a focus on the adaptation and clinical validation of molecular, cellular, and imaging markers for cancer detection, diagnosis, prognosis, monitoring, treatment response, and cancer control and prevention. Research applications may support the acquisition of well-annotated specimens from NCI-supported or other clinical trials or observational cohorts/consortia for the purpose of clinical validation of the assay. This NOFO is assigned to the Cancer Detection and Diagnosis Research federal grant program under the Department of Health and Human Services National Institutes of Health. Eligible applicant types include a variety of public and private organizations, and the funding instrument is a grant.